VIVEbiotech expands its global reach with Korean and Japanese versions of its website

VIVEbiotech has added Korean and Japanese versions to its corporate website, expanding access to its content for customers, partners, and gene therapy developers across key international markets.

This update is part of the company’s global growth strategy and reinforces its commitment to making information about its activities, services, and capabilities more accessible to an increasingly international audience.

As VIVEbiotech continues to strengthen collaborations across international markets, the company remains committed to advancing innovative gene therapies through robust and scalable lentiviral vector manufacturing solutions.

With a strong track record in ex vivo gene therapy programmes and experience supporting more than 15 in vivo programmes to date, including two already in the clinic, VIVEbiotech continues to support developers throughout the evolving advanced therapy landscape.

The addition of these new language versions represents another step in bringing VIVEbiotech’s expertise and capabilities closer to the global gene therapy community and supporting its continued international growth.